REAL BROKERAGE INC/THE (REAX) Fundamental Analysis & Valuation

NASDAQ:REAX • CA75585H2063

Current stock price

2.22 USD
+0.2 (+9.9%)
At close:
2.2491 USD
+0.03 (+1.31%)
After Hours:

This REAX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. REAX Profitability Analysis

1.1 Basic Checks

  • In the past year REAX has reported negative net income.
  • In the past year REAX had a positive cash flow from operations.
  • REAX had negative earnings in each of the past 5 years.
  • REAX had a positive operating cash flow in each of the past 5 years.
REAX Yearly Net Income VS EBIT VS OCF VS FCFREAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -6.39%, REAX is doing worse than 67.74% of the companies in the same industry.
  • REAX has a Return On Equity of -15.68%. This is in the lower half of the industry: REAX underperforms 61.29% of its industry peers.
Industry RankSector Rank
ROA -6.39%
ROE -15.68%
ROIC N/A
ROA(3y)-26.55%
ROA(5y)-31.19%
ROE(3y)-57.61%
ROE(5y)-61.83%
ROIC(3y)N/A
ROIC(5y)N/A
REAX Yearly ROA, ROE, ROICREAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K

1.3 Margins

  • REAX has a Gross Margin of 8.42%. This is in the lower half of the industry: REAX underperforms 69.35% of its industry peers.
  • In the last couple of years the Gross Margin of REAX has declined.
  • The Profit Margin and Operating Margin are not available for REAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y-8.68%
REAX Yearly Profit, Operating, Gross MarginsREAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. REAX Health Analysis

2.1 Basic Checks

  • REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, REAX has more shares outstanding
  • Compared to 5 years ago, REAX has more shares outstanding
  • REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REAX Yearly Shares OutstandingREAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
REAX Yearly Total Debt VS Total AssetsREAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • REAX has an Altman-Z score of 17.71. This indicates that REAX is financially healthy and has little risk of bankruptcy at the moment.
  • REAX's Altman-Z score of 17.71 is amongst the best of the industry. REAX outperforms 96.77% of its industry peers.
  • REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.71
ROIC/WACCN/A
WACC8.99%
REAX Yearly LT Debt VS Equity VS FCFREAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • REAX has a Current Ratio of 1.41. This is a normal value and indicates that REAX is financially healthy and should not expect problems in meeting its short term obligations.
  • REAX's Current ratio of 1.41 is in line compared to the rest of the industry. REAX outperforms 45.16% of its industry peers.
  • A Quick Ratio of 1.41 indicates that REAX should not have too much problems paying its short term obligations.
  • The Quick ratio of REAX (1.41) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
REAX Yearly Current Assets VS Current LiabilitesREAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. REAX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 78.57% over the past year.
  • REAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 55.65%.
  • Measured over the past years, REAX shows a very strong growth in Revenue. The Revenue has been growing by 159.90% on average per year.
EPS 1Y (TTM)78.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)55.65%
Revenue growth 3Y72.75%
Revenue growth 5Y159.9%
Sales Q2Q%44.07%

3.2 Future

  • The Earnings Per Share is expected to grow by 106.46% on average over the next years. This is a very strong growth
  • REAX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.54% yearly.
EPS Next Y72.8%
EPS Next 2Y73.78%
EPS Next 3Y106.46%
EPS Next 5YN/A
Revenue Next Year21.89%
Revenue Next 2Y18.9%
Revenue Next 3Y19.54%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
REAX Yearly Revenue VS EstimatesREAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
REAX Yearly EPS VS EstimatesREAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2

More info and screens

Find the best growth stocksShow best growing peers

2

4. REAX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for REAX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REAX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REAX Price Earnings VS Forward Price EarningsREAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

  • 93.55% of the companies in the same industry are more expensive than REAX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.53
EV/EBITDA N/A
REAX Per share dataREAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • A more expensive valuation may be justified as REAX's earnings are expected to grow with 106.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.78%
EPS Next 3Y106.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. REAX Dividend Analysis

5.1 Amount

  • REAX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

REAX Fundamentals: All Metrics, Ratios and Statistics

REAL BROKERAGE INC/THE

NASDAQ:REAX (4/28/2026, 8:00:01 PM)

After market: 2.2491 +0.03 (+1.31%)

2.22

+0.2 (+9.9%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-04
Earnings (Next)05-07
Inst Owners44.15%
Inst Owner Change-0.49%
Ins Owners7.24%
Ins Owner ChangeN/A
Market Cap467.27M
Revenue(TTM)1.97B
Net Income(TTM)-8.11M
Analysts85
Price Target5.51 (148.2%)
Short Float %4.6%
Short Ratio4.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.83%
Min EPS beat(2)39.67%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)122.06%
Min EPS beat(4)39.67%
Max EPS beat(4)292.16%
EPS beat(8)7
Avg EPS beat(8)67.19%
EPS beat(12)9
Avg EPS beat(12)40.87%
EPS beat(16)11
Avg EPS beat(16)30.12%
Revenue beat(2)2
Avg Revenue beat(2)4.36%
Min Revenue beat(2)4.31%
Max Revenue beat(2)4.42%
Revenue beat(4)4
Avg Revenue beat(4)5.71%
Min Revenue beat(4)4.24%
Max Revenue beat(4)9.88%
Revenue beat(8)8
Avg Revenue beat(8)11.02%
Revenue beat(12)12
Avg Revenue beat(12)13.96%
Revenue beat(16)16
Avg Revenue beat(16)17.61%
PT rev (1m)-8.86%
PT rev (3m)-14.74%
EPS NQ rev (1m)44%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)60%
EPS NY rev (3m)60%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)2.64%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF 7.53
P/OCF 7.09
P/B 9.04
P/tB 12.13
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.29
FCFY13.28%
OCF(TTM)0.31
OCFY14.11%
SpS9.35
BVpS0.25
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.39%
ROE -15.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.42%
FCFM 3.15%
ROA(3y)-26.55%
ROA(5y)-31.19%
ROE(3y)-57.61%
ROE(5y)-61.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5Y-8.68%
F-Score7
Asset Turnover15.52
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 199.59%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 17.71
F-Score7
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)110.07%
Cap/Depr(5y)167.69%
Cap/Sales(3y)0.12%
Cap/Sales(5y)0.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y72.8%
EPS Next 2Y73.78%
EPS Next 3Y106.46%
EPS Next 5YN/A
Revenue 1Y (TTM)55.65%
Revenue growth 3Y72.75%
Revenue growth 5Y159.9%
Sales Q2Q%44.07%
Revenue Next Year21.89%
Revenue Next 2Y18.9%
Revenue Next 3Y19.54%
Revenue Next 5YN/A
EBIT growth 1Y63.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year792.58%
EBIT Next 3Y129.47%
EBIT Next 5YN/A
FCF growth 1Y30.18%
FCF growth 3Y138.25%
FCF growth 5YN/A
OCF growth 1Y35.29%
OCF growth 3Y122.32%
OCF growth 5YN/A

REAL BROKERAGE INC/THE / REAX Fundamental Analysis FAQ

What is the fundamental rating for REAX stock?

ChartMill assigns a fundamental rating of 4 / 10 to REAX.


Can you provide the valuation status for REAL BROKERAGE INC/THE?

ChartMill assigns a valuation rating of 2 / 10 to REAL BROKERAGE INC/THE (REAX). This can be considered as Overvalued.


How profitable is REAL BROKERAGE INC/THE (REAX) stock?

REAL BROKERAGE INC/THE (REAX) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for REAX stock?

The Earnings per Share (EPS) of REAL BROKERAGE INC/THE (REAX) is expected to grow by 72.8% in the next year.